Changing epidemiology of methicillin-resistant Staphylococcus aureus in Alberta, Canada: Population-based surveillance, 2005-2008

Epidemiology and Infection

Volumn 139, Issue 7, 2011, Pages 1009-1018

  Kim, J ^a   Ferrato, C ^b   Golding, G R ^c   Mulvey, M R ^c   Simmonds, K A ^d   Svenson, L W ^d,e   Keays, G ^e   Chui, L ^b,e   Lovgren, M ^b   Louie, M ^a,b,f  

^a UNIVERSITY OF CALGARY   (Canada)

^b ALBERTA HEALTH SERVICES   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d Surveillance and Assessment   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

Author keywords

Epidemiology; infectious disease; methicillin resistant S. aureus (MRSA); public health

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; LINEZOLID; PSEUDOMONIC ACID; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CANADA; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; HUMAN; INCIDENCE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; POPULATION BASED CASE CONTROL STUDY; PRESCHOOL CHILD; PROSPECTIVE STUDY; PUBLIC HEALTH PROBLEM; SCHOOL CHILD; SEX RATIO;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALBERTA; BACTERIAL TYPING TECHNIQUES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; SEX FACTORS; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 79959363309     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268810002128     Document Type: Article

References (37)

1. Stefani S, Varaldo PE. Epidemiology of methicillin-resistant staphylococci in Europe. Clinical Microbiology and Infection 2003; 9: 1179-1186. (Pubitemid 38035079)
2. Jarvis WR, et al. National prevalence of methicillin-resistant Staphylococcus aureus inpatients at US health care facilities, 2006. American Journal of Infection Control 2007; 35: 631-637.
3. European Antimicrobial Resistance Surveillance System. Annual report 2008 (http://www.rivm.nl/earss/result/ Monitoring-reports/). Accessed 10 June 2010.
4. Hiramatsu K, et al. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends in Microbiology 2001; 9: 486-493. (Pubitemid 32939356)
5. Mulvey MR, et al. Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis. Journal of Clinical Microbiology 2001; 39: 3481-3485. (Pubitemid 32954488)
6. Tenover FC, et al. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. Journal of Clinical Microbiology 2006; 44: 108-118. (Pubitemid 43100588)
7. Simor AE, et al. Characterization and proposed nomenclature of epidemic strains of MRSA in Canada. Canadian Journal of Infectious Diseases 1999; 10: 333-336.
8. Christianson S, et al. Comparative genomics of Canadian epidemic lineages of methicillin-resistant Staphylococcus aureus. Journal of Clinical Microbiology 2007; 45: 1904-1911. (Pubitemid 46933925)
9. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. Journal of the American Medical Association 1999; 282: 1123-1125.
10. Herold BC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. Journal of the American Medical Association 1998; 279: 593-598. (Pubitemid 28110205)
11. Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clinical Infectious Diseases 2008; 46: S344-349.
12. Moran GJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. New England Journal of Medicine 2006; 355: 666.
13. King MD, et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Annals Internal Medicine 2006; 144: 309-317. (Pubitemid 46768185)
14. Klevens RM, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Journal of the American Medical Association 2007; 298: 1763-1771. (Pubitemid 47598444)
15. Simor AE, et al. Methicillin-resistant Staphylococcus aureus colonization or infection in Canada: national surveillance and changing epidemiology, 1995-2007. Infection Control and Hospital Epidemiology 2010; 31: 348-356.
16. Gilbert M, et al. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. Canadian Medical Association Journal 2006; 175: 149-154. (Pubitemid 44126248)
17. Tenover FC, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis : criteria for bacterial strain typing. Journal of Clinical Microbiology 1995; 33: 2233-2239.
18. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 17th informational supplement. CLSI document MS 100-S17. Wayne, PA: CLSI; 2007.
19. Walker ES, et al. A decline in mupirocin resistance in methicillin-resistant Staphylococcus aureus accompanied administrative control of prescriptions. Journal of Clinical Microbiology 2004; 42: 2792-2795. (Pubitemid 38747542)
20. Skov R, Frimodt-Møller N, Espersen F. Correlation of MIC methods and tentative interpretive criteria for disk diffusion susceptibility testing using NCCLS methodology for fusidic acid. Diagnostic Microbiology and Infectious Disease 2001; 40: 111-116. (Pubitemid 32735548)
21. Zar JH. Biostatistical Analysis, 4th edn. New Jersey : Prentice Hall, 1999.
22. Cimolai N. Methicillin-resistant Staphylococcus aureus in Canada: a historical perspective and lessons learned. Canadian Journal of Microbiology 2010; 56: 89-120.
23. Fridkin SK, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. New England Journal of Medicine 2005; 352: 1436-1444.
24. Liu C, et al. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. Clinical Infectious Diseases 2008; 46: 1637-1646.
25. Huang H, et al. Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California. Journal of Clinical Microbiology 2006; 44: 2423-2427. (Pubitemid 44092406)
26. Patel M, et al. Emergence of USA300 MRSA in a tertiary medical centre : implications for epidemiological studies. Journal of Hospital Infection 2008; 68: 208-213.
27. Naimi TS, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. Journal of the American Medical Association 2003; 290: 2976-2984. (Pubitemid 37505530)
28. Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Annals of Internal Medicine 1982; 97: 309-317. (Pubitemid 12061576)
29. Monnet DL. Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: possible implications for control. Infection Control and Hospital Epidemiology 1998; 19: 552-559. (Pubitemid 128472678)
30. Simmonds KA, et al. Epidemiology of community associated methicillin-resistant Staphylococcus aureus. Canada Communicable Disease Report 2008; 34: 1-9.
31. Simor AE, et al. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrobial Agents and Chemotherapy 2007; 51: 3880-3886. (Pubitemid 350057784)
32. Deurenberg RH, Stobberingh EE. The Evolution of Staphylococcus aureus. Infection, Genetics and Evolution 2008; 8: 747-763.
33. DeLeo FR, Chambers HF. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomic era. Journal of Clinical Investigation 2009; 119: 2464-2474.
34. Hawkes M, et al. Community-associated MRSA: superbug at our doorstep. Canadian Medical Association Journal 2007; 176: 54-56. (Pubitemid 46144744)
35. Klevens M, et al. Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerging Infectious Diseases 2006; 12: 1991-1993.
36. Allen UD. Public health implications of MRSA in Canada. Canadian Medical Association Journal 2006; 175: 161.
37. Patel M, et al. Dissemination of community-associated methicillin-resistant Staphylococcus aureus in a tertiary care hospital. Southern Medical Journal 2008; 101: 40-45.